文献速递皮肤肿瘤

四肢痣计数是基底细胞癌和黑色素瘤的独立危险因素,但与鳞状细胞癌无关

Extremity nevus count is an independent risk factor for basal cell carcinoma and melanoma, but not squamous cell carcinoma.
PubMed 文献 · J Am Acad Dermatol · 2019-01-31

该研究基于护士健康研究(1986-2012/1989-2013)和卫生专业人员随访研究(1986-2012)的前瞻性队列,共纳入176,317名女性和32,383名男性,评估基线四肢痣计数与黑色素瘤及角质形成细胞癌风险的关系。结果显示,四肢痣存在与所有解剖部位的黑色素瘤和基底细胞癌风险增加相关,≥15个痣者风险最高(黑色素瘤HR 2.79,95%CI 2.04-3.83;BCC HR 1.40,95%CI 1.32-1.49),但与鳞状细胞癌无显著关联。

要点

  • 四肢痣计数可帮助临床医生对黑色素瘤和基底细胞癌进行风险分层。
  • ≥15个四肢痣者黑色素瘤风险是无痣者的2.79倍,BCC风险为1.40倍。
  • 四肢痣计数与鳞状细胞癌风险无显著关联。

核心结论

  • 四肢痣计数是基底细胞癌和黑色素瘤的独立危险因素,但与鳞状细胞癌无关。

研究设计与样本

  • 前瞻性队列研究,纳入护士健康研究(1986-2012)和护士健康研究2(1989-2013)共176,317名女性,以及卫生专业人员随访研究(1986-2012)共32,383名男性。
  • 基线收集四肢痣计数信息(无、1-5、6-14、≥15个)。
  • 黑色素瘤随访总人年数为4,655,043,角质形成细胞癌随访总人年数为4,267,708。

主要发现

  • 发生黑色素瘤1,704例,鳞状细胞癌2,296例,基底细胞癌30,457例。
  • 四肢痣存在与所有解剖部位的黑色素瘤风险增加及基底细胞癌风险增加相关。
  • 与无四肢痣者相比,≥15个痣者黑色素瘤风险最高(HR 2.79,95%CI 2.04-3.83),基底细胞癌风险也最高(HR 1.40,95%CI 1.32-1.49)。
  • 鳞状细胞癌未见显著关联。

关键数值与推荐

  • 四肢痣计数分组:无、1-5、6-14、≥15个。
  • ≥15个四肢痣 vs 无痣:黑色素瘤HR 2.79(95%CI 2.04-3.83),基底细胞癌HR 1.40(95%CI 1.32-1.49)。

临床怎么用

  • 四肢痣计数可作为临床标记,用于对黑色素瘤和基底细胞癌进行风险分层。
  • 对于四肢痣数量较多(尤其≥15个)的个体,应考虑加强黑色素瘤和基底细胞癌的筛查与监测。

局限性

  • 痣计数为自我报告。
  • 存在检测偏倚。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The presence of nevi portends an increased risk for melanoma. OBJECTIVE: We sought to examine the association between extremity nevus count and the risk of melanoma and keratinocyte cancers. METHODS: We evaluated prospective cohorts of 176,317 women (the Nurses' Health Study, 1986-2012 and the Nurses' Health Study 2, 1989-2013) and 32,383 men (Health Professionals Follow-up Study, 1986-2012). Information on nevus count (none, 1-5, 6-14, ≥15) on the extremity was collected at baseline. RESULTS: There were 1704 incident cases of melanoma, 2296 incident cases of squamous cell carcinoma, and 30,457 incident cases of basal cell carcinoma, with a total of 4,655,043 person-years for melanoma and 4,267,708 person-years for keratinocyte cancers. The presence of an extremity nevus was associated with an increased risk of melanoma in all anatomic areas and increased risk of basal cell carcinoma (BCC). Individuals with ≥15 nevi had the highest risk of melanoma and BCC compared to those without any extremity nevi (melanoma hazard ratio 2.79 [95% confidence interval 2.04-3.83]; BCC HR 1.40 [95% confidence interval 1.32-1.49]). No significant association was observed for squamous cell carcinoma. LIMITATIONS: Limitations of our study included self-reported nevus count and detection bias. CONCLUSIONS: Extremity nevus count is a helpful clinical marker in risk-stratifying individuals for BCC and melanoma on all body sites.

来源:J Am Acad Dermatol,查看原文。版权归原作者所有。

引用

  1. Wei EX, Li X, Nan H, et al. Extremity nevus count is an independent risk factor for basal cell carcinoma and melanoma, but not squamous cell carcinoma. J Am Acad Dermatol. 2019. PMID: 30713015. doi:10.1016/j.jaad.2018.09.044

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。